Trials / Completed
CompletedNCT00737997
Effect of Early Morphine Administration on the Development of Acute Opioid Tolerance During Pediatric Scoliosis Surgery
Effect of Early Administration of Morphine on the Development of Acute Opioid Tolerance During Infusion of Remifentanil for Pediatric Scoliosis Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- The Hospital for Sick Children · Academic / Other
- Sex
- All
- Age
- 11 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine if morphine administered by bolus before initiating Remifentanil by infusion decreases the incidence of acute post-operative opioid tolerance as demonstrated by decreased post - operative morphine consumption in children undergoing scoliosis surgery.
Detailed description
At our institution, a study has recently demonstrated that intraoperative infusion of remifentanil is associated with development of clinically relevant acute opioid tolerance in adolescents undergoing scoliosis surgery. This results in increased morphine consumption which in turn is associated with increased incidence of side effects such as respiratory depression, nausea and vomiting, pruritus, ileus and urinary retention. All of these side effects can result in increased consumption of rescue medications with the additional potential for increased duration of patient stay. Any measures that can be introduced to decrease the development of acute opioid tolerance in this patient population would have significant impact on patient morbidity, patient comfort and possibly duration of patient stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Morphine | 150 mcg/kg diluted in normal saline to a volume of 10 ml at time of induction of anesthesia |
| OTHER | Saline | 10 ml saline alone |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-12-01
- Completion
- 2008-02-01
- First posted
- 2008-08-20
- Last updated
- 2014-11-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00737997. Inclusion in this directory is not an endorsement.